BUTALBITAL and ACETAMINOPHEN
Active substance: BUTALBITAL, ACETAMINOPHEN
TABLET · BUTALBITAL 50 mg/1, ACETAMINOPHEN 300 mg/1
United StatesActive
Marketing holder: QUAGEN PHARMACEUTICALS LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- BUTALBITAL · 50 mg/1
- ACETAMINOPHEN · 300 mg/1
Registration
- Registration number
- 70752-147
- Registration status
- Active
- Dispensing
- Prescription only
- Control marker
- CIII
- Route
- ORAL
Sources
- product · openFDA NDC · 70752-147 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 70752-147 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 70752-147 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 70752-147 · Verified 2026-10-09 · open in source